X-Chem
在场
X-Chem 的所有者是 GHO Capital.
GHO Capital 在 2 个国家有直接业务。
GHO Capital 拥有 3家子公司，其中包括 DNA Diagnostics Center、Velocity Clinical Research 和 X-Chem。
他们在：
高管
查看带有其 14 名主要高管的组织结构图
X-Chem 搜索最多的简介
- Karen Lackey, Chief Executive Officer
- Anthony Keefe, Senior Vice President, Alliance Management and Inno...
- Matthew Clark, President and Chief Scientific Officer
高管在X-Chem变化
- Paul Davie已作为Chief Business Officer加入公司 (新闻发布的2024六月21号).
创建提醒
跟踪 X-Chem 的高管变动
生物技术
GHO Capital 拥有 2,317 家竞争者，其中包括 Eurofins (卢森堡)、Lonza (瑞士) 和 Biogen (美国(美洲))。
Popular M&A news in 生物技术
- AgomAb Therapeutics 刚刚宣布为 89 筹款数百万美元。 (公布2024十月29号).
- Seaport Therapeutics 刚刚宣布为 225 筹款数百万美元。 (公布2024十月25号).
- TuHura Biosciences and Kintara Therapeutics have merged (公布2024十月20号)..
生物技术 行业的其他推荐联系人
消息
X-Chem 的最新新闻稿
- Tonix Pharmaceuticals Announces AI Collaboration with X-Chem to Develop Broad-Spectrum Antivirals | X-Chem
- X-Chem Announces Candidate Milestone | X-Chem
- Evotec and X-Chem Collaborate to Accelerate Early-Stage Drug Discovery | X-Chem
- Cancer Research Horizons appoints Therapeutic Innovation board to drive drug discovery strategy | X-Chem
- X-Chem Strengthens Its Data-Driven Discovery Services With New CBO Appointment | X-Chem
- X‑Chem Adds Chief Technology Officer to Bolster Its Digital Drug Discovery Strategy | X-Chem
- Fibrolamellar Cancer Foundation: New research collaboration with X‑Chem | X-Chem
- X‑Chem Transitions Executives into New Roles, Appoints New Chief Executive Officer | X-Chem
- 2024 | X-Chem
- X-Chem Announces Achievement of Collaboration Milestone | X-Chem
- View more press releases Close
通过电子邮件
